The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Open accessAbstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breast cancer has become the most commonly diagnosed cancer worldwide, surpassing lung cancer [1, 2].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of primary prevention, a reduction in excess body weight and alcohol consumption and increasing physical activity and breastfeeding may have an impact in reducing breast cancer incidence.58”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Secretan, B., Scoccianti, C., LOOMIS, D. P., Benbrahim‐Tallaa, L., Bouvard, V., Bianchini, F., & Straíf, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 966
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Song, Y., Xia, K., Wu, X., Zeng, C., Tang, S., Yuan, Y., Gui, Y., Zhang, X., & Zhong, H. (2023) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4655 · Cited by 7
Upadhyay, A. K., & Prakash, A. (2023) · Cureus · doi:10.7759/cureus.39990 · Cited by 7
Zhivkova, T., Culita, D. C., Abudalleh, A., Dyakova, L., Mocanu, T., Mădălan, A. M., Georgieva, M., Miloshev, G. A., Hanganu, A., Marinescu, G., et al. (2023) · Dalton Transactions · doi:10.1039/d3dt01749d · Cited by 7
Oliveira, D. S., Lapierre, T. J. W. J. D., SILVA, F. A. B. N. D., da Cunha, I. V., Souza, R., Matos, P., Almeida, G., Oliveira, C. G., Araújo, T. G., Tsubone, T. M., et al. (2023) · Journal of the Brazilian Chemical Society · doi:10.21577/0103-5053.20230128 · Cited by 7
Hussen, B. M., Hidayat, H. J., Abdullah, S. R., Mohamadtahr, S., Rasul, M. F., Samsami, M., & Taheri, M. N. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156351 · Cited by 7
Xu, Y., Cao, J., Gong, K., Li, S., Liu, Y., Xiong, F., Pan, Y., Chen, M., Gong, J., Luo, N., et al. (2023) · PubMed Central · Cited by 7
Abirami, A., Umapathy, D., Ramesh, R., Arockiam, A. J. V., & Małecki, J. G. (2023) · Dalton Transactions · doi:10.1039/d3dt02552g · Cited by 7
Mohaideen, N. S. M. H., Ravindranath, K. J., & Srinivasan, H. (2023) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2023.102952 · Cited by 7
Abdullah, A. R., El-Din, A. M. G., El‐Mahdy, H. A., Ismail, Y. M., & El-Husseiny, A. A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155079 · Cited by 7
Song, B., Hou, G., Xu, M., & Chen, M. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111101 · Cited by 7
Jahromi, M. K., Ahmadirad, H., Farhadnejad, H., Norouzzadeh, M., Mokhtari, E., Teymoori, F., Saber, N., Heidari, Z., Mirmiran, P., & Rashidkhani, B. (2024) · BMC Women s Health · doi:10.1186/s12905-024-02959-7 · Cited by 7
Situmorang, P. C., Ilyas, S., Syahputra, R. A., Sari, R. M., Nugraha, A. P., & Ibrahim, A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1345645 · Cited by 7
RetractedAttia, H., Kamel, M. M., Ayoub, D. F., Aziz, S. H. A. E., Wahed, M. M. A., El-Fattah, S. N. A., Ablel-Monem, M. A., Rabah, T. M., Helal, A. M., & Ibrahim, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-58104-9 · Cited by 7
Zhan, H., Ding, S., Shen, R., Lv, Y., Tian, X., Liu, G., Li, C., & Wang, J. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206296123240331050206 · Cited by 7
Glucosyltriazole amphiphile treatment attenuates breast cancer by modulating the AMPK signaling
Chouhan, N. K., Eedara, A., Talati, M. N., Ambadipudi, S. S. S. S. S., Andugulapati, S. B., & Pabbaraja, S. (2024) · Drug Development Research · doi:10.1002/ddr.22215 · Cited by 7
Amraee, N., Majd, A., Torbati, M. B., & Shaabanzadeh, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2507864/v1 · Cited by 7
Heshmati, R., Azmoodeh, S., Kheiriabad, M., Ghasemi, A., & Lo, C. (2023) · Current Oncology · doi:10.3390/curroncol30050389 · Cited by 6
Kassem, T. Z., Wunderle, M., Kuhlmann, L., Ruebner, M., Huebner, H., Hoyer, J., Reis, A., Fasching, P. A., Beckmann, M. W., Hack, C. C., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080418 · Cited by 6
Nascimento, C. S., Tavares, N. C., Batista, I. C. A., Caetano, M. M. M., de Oliveira, E. S., Colombarolli, S. G., Lage, A. C. P., Corrêa‐Oliveira, R., Alves, É. A. R., de Melo, C. P., et al. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00225-3 · Cited by 6
Gupta, J., Thombre, K. R., Gupta, K. R., & Umekar, M. J. (2024) · Letters in Organic Chemistry · doi:10.2174/0115701786287193240215101054 · Cited by 10
Anh, N. Q., Oanh, T. T. M., Nguyen, P. K., & Thu, H. N. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300474 · Cited by 6
Kebede, S. S., Alemu, T., & Mekonnen, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1352191 · Cited by 6
Chaudhary, P., Yadav, K., Lee, H. J., Kang, K. W., Mo, J., & Kim, J. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01827-4 · Cited by 7
Qurtam, A. A., & Nasr, F. A. (2024) · Journal of Animal and Feed Sciences · doi:10.22358/jafs/187176/2024 · Cited by 6
Yu, L., Gong, J., Sun, X. S., Zang, M., Liu, L., & Yu, S. (2024) · Journal of Medical Internet Research · doi:10.2196/53872 · Cited by 6
Banthia, P., Vyas, R., Jain, A., Daga, D., Ichikawa, T., Kulshrestha, V., Sharma, A., Agarwal, R., Kapoor, N., Gambhir, L., et al. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2347825 · Cited by 6
Yamani, N., Ahmed, A. B., Khan, M. A., Wilson, Z., Shakoor, M., Qadri, S. F., Unzek, S., Silver, M. A., & Mookadam, F. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00235-z · Cited by 6
Li, Z., Wang, J., Peng, Q., Jiang, N., Wei, Y., Liu, H., & zhang, M. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2907239 · Cited by 6
HPV Detection in Breast Tumors and Associated Risk Factors in Northeastern Brazil
Nascimento, K. C. G., Marcos, B. D. F. S., Fontes, P. H. B., Isídio, B. E. D. O., Leão, S. L., da Silva, G. R. P., Lussón, D. B., dos Santos, D. L., Leal, L. R. S., Espinoza, B. C. F., et al. (2024) · Cells · doi:10.3390/cells13131132 · Cited by 6
Mo, W., Ke, Q., Yang, Q., Zhou, M., Xie, G., Qi, D., Peng, L., Wang, X., Wang, F., Ni, S., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00870 · Cited by 6
Li, F., Ma, J., Wen, T., Tian, Z., & Liang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38410 · Cited by 6
Guo, X. (2024) · American Journal of Cancer Research · doi:10.62347/yawk6271 · Cited by 6
Dissecting the epigenetic orchestra of HDAC isoforms in breast cancer development: a review
Debbarma, M., Sarkar, K., & Sil, S. K. (2024) · Medical Oncology · doi:10.1007/s12032-024-02553-9 · Cited by 7
The productivity burden of breast cancer in Australia
Lloyd, M., Bassi, D., Zomer, E., & Ademi, Z. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102726 · Cited by 6
Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity
Arrey, E. N., Gopaul, D. A., Anderson, D. B., Okoli, J., & McKenzie‐Johnson, T. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.28011 · Cited by 6
Essa, A. F., Elghonemy, M. M., Taher, R. F., Allam, R. M., & Elshamy, A. I. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114418 · Cited by 6
Li, X., Su, X., Liang, W., Wang, L., Yuan, C., Xu, J., Zhang, Y., Liu, Y., Ma, N., Yang, F., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107630 · Cited by 6
Belazizia, K., Benslama, O., Bouchene, R., Berrah, F., Köhn, R. D., Kociok-Köhn, G. I., Chebbah, M., Bouhenguel, M., & Bouchemma, A. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.141662 · Cited by 6
Alwateer, M. M., Bamaqa, A., Farsi, M., Aljohani, M., Shehata, M., & Elhosseini, M. A. (2025) · Bioengineering · doi:10.3390/bioengineering12030212 · Cited by 6
van Maaren, M. C., Voorham, Q. J. M., Wijnen, E. M., de Munck, L., Wesseling, J., Visser, O. J., & Siesling, S. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102780 · Cited by 6
Self-citationThe effect of body mass index on breast cancer stage and breast cancer specific survival
Bellini, A. R., Keegan, T. H. M., Li, Q., Jacinto, A. M. L., Maguire, F. B., Lyo, V., & Sauder, C. A. M. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07678-7 · Cited by 6
Rajagopal, P. S., Reid, S., Fan, R., Venton, L., Weidner, A. E., Roberson, M. L., Vadaparampil, S. T., Wang, X., Yoder, S., Rosa, M., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00731-0 · Cited by 6
Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells
Doddapaneni, R., Tucker, J. D., Lu, P., & Lu, Q. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062661 · Cited by 6
Zooravar, D., Radkhah, H., Amiri, B. S., & Soltani, P. (2025) · Cancer Reports · doi:10.1002/cnr2.70194 · Cited by 8
Tang, H., Zhang, W., Li, X., Zou, Q., Li, X., Liu, Y., & Shen, H. (2025) · BMC Cancer · doi:10.1186/s12885-025-13991-7 · Cited by 6
A Review of Advanced Deep Learning Methods of Multi-Target Segmentation for Breast Cancer WSIs
Xu, Q., Adam, A., Abdullah, A., & Baharun, N. B. (2025) · IEEE Access · doi:10.1109/access.2025.3565648 · Cited by 6
Wilhelm, A., Flynn, C., Hammer, E., Roessler, J., Haller, B., Napieralski, R., Leuthner, M., Tosheska, S., Knoops, K., Mathew, A., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02056-z · Cited by 6
Dosunmu, D. P., Abolade, R. O., Bashiru, M., Owolade, A. J.-J., Samuel, M. K., Boluwatife, E. O., Olatunya, A. M., Aribisala, P. O., Osunnaya, S. A., Oladosu, M. A., et al. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100092 · Cited by 6
Ferrigno, A. S., Salazar-Alejo, M., Mesa-Chávez, F., Gutiérrez-Ornelas, J., Platas, A., Verduzco-Aguirre, H. C., & Villarreal-Garza, C. M. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09681-6 · Cited by 6
Wang, S., Liu, J., Song, L., Zhao, H., Wan, X., & Peng, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-14556-4 · Cited by 6
Wang, R., Zhang, Y., Du, S., Li, Y., Ren, Y., & Lin, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520329 · Cited by 8
Çavdar, V. C., Aric, M., Rakıcı, İ. T., Gültürk, İ., Karaca, Z. B., Afşar, Ç. U., Akdağ, G., Gürsu, R. U., Han, O., & Ballica, B. (2025) · Medicine · doi:10.1097/md.0000000000043374 · Cited by 6
Hasyim, D. M., Musfiroh, I., Hendra, R., Fakih, T. M., Ikram, N. K. K., & Muchtaridi, M. (2025) · Applied Sciences · doi:10.3390/app15158444 · Cited by 6
Green-synthesized silver nanoparticles: a sustainable nanoplatform for targeted colon cancer therapy
Dohare, S., Khandal, J., Dongsar, T. S., Gupta, G., Sahebkar, A., Abourehab, M. A. S., & Kesharwani, P. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126015 · Cited by 6
Lightweight Mamba Model for 3D Tumor Segmentation in Automated Breast Ultrasounds
Kim, J., Kim, J., Dharejo, F. A., Abbas, Z., & Lee, S. W. (2025) · Mathematics · doi:10.3390/math13162553 · Cited by 7
Auni, N. M. A. N. A., Redzwan, N. M., Yahya, M. M., & Wong, K. K. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2545364 · Cited by 6
Michalczyk, M., Humeniuk, E., Kubik, J., Adamczuk, G., Michalczuk, M., Madej, B., Czerwonka, M., & Korga-Plewko, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-16681-3 · Cited by 6
Lastrucci, A., Iosca, N., Wandael, Y., Barra, A., Ricci, R., Cucchiari, J. N., Forini, N., Lepri, G., & Giansanti, D. (2025) · Diagnostics · doi:10.3390/diagnostics15172197 · Cited by 7
Nhung, T. T. P. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i8.7 · Cited by 6
Khmel, O. O., Yurchenko, A. N., Trinh, P. T. H., Ngoc, N. T. D., Trang, V. T. D., Khánh, H. H. N., Antonov, A. S., Drozdov, K. A., Popov, R. S., Kim, N. Y., et al. (2025) · Marine Drugs · doi:10.3390/md23090353 · Cited by 6
Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology
Jeong, W., & Lee, S. J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503104 · Cited by 8
Cheriyan, B., Nandhini, J., & Devaraji, M. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00502-2 · Cited by 6
Theivendren, P., Gopalakrishnan, P., Sivakumar, A., Pachiappan, S., Chimakurthy, J., & Murugavel, A. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100375 · Cited by 7
Current state of elastography research in multiple anatomical structures and respective phantoms
Santos, A. Z., Rocha, S., Carneiro, B., Fernandes, N. A. T. C., Padrão, J., & Carvalho, Ó. S. N. (2025) · Physica Medica · doi:10.1016/j.ejmp.2025.105192 · Cited by 6
Yan, W., Zhou, H., Huang, Y., Zhang, Y., Wang, S., & Yu, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1681487 · Cited by 6
Telerehabilitation in Postoperative Breast Cancer Care: Systematic Review and Meta-Analysis
Santacaterina, F., Campagnola, B., Bressi, F., Zollo, L., Sterzi, S., & Bravi, M. (2025) · JMIR Rehabilitation and Assistive Technologies · doi:10.2196/77161 · Cited by 6
Masarkar, N., Pal, M., Bisai, A., Yadav, A. K., Roy, M., Ray, S. K., Kanwar, J. R., & Mukherjee, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-20757-5 · Cited by 6
Multiomics Machine Learning to Predict Neoadjuvant Chemotherapy Outcome and Relapse of Breast Cancer
Wang, L., Zhang, X., Zhang, J., Li, J., Chen, Y., Huang, W., & Xie, X. (2025) · BME Frontiers · doi:10.34133/bmef.0212 · Cited by 6
Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer
Dumas, É., Hamy, A., Wanis, K. N., Jochum, F., Coussy, F., Giacchetti, S., Gaillard, T., Laas, E., Houzard, S., Bihan-Benjamin, C. L., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.50842 · Cited by 9
Sathish, S., Ponnusamy, K., & Madhavan, T. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10617-8 · Cited by 6
Agrawal, T., Paul, D., Saroj, S., Ali, A., Choubey, V., Mukherjee, D., Pal, S., & Rakshit, T. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00147 · Cited by 6
Safar, H. M., & Mazanec, S. R. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.4.1435 · Cited by 6
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
Motyka, J., Gacuta, E., Kicman, A., Kulesza, M., Malinowski, P., & Ławicki, S. (2023) · Cancer Management and Research · doi:10.2147/cmar.s416382 · Cited by 7
Çelik, B., Uğur, S. B., Baran, M., Gündüz, M. G., Keskin, S., Önder, G. Ö., Bıtgen, N., Kaya, S., & Doğan, Ş. D. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300609 · Cited by 6
Liu, L., Hu, J.-H., Pan, J., Liu, H., Ji, F., & Peng, K. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s421265 · Cited by 6
Raheem, A. R., Abdul‐Rasheed, O. F., Khattab, O. S., Alsammarraie, A. Z., Al-Aubaidy, H. A., & Abid, H. A. (2024) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-023-01174-9 · Cited by 6
Sidibe, M., Tazzite, A., Jouhadi, H., & Dehbi, H. (2023) · Journal of Current Oncology · doi:10.1177/25898892231223300 · Cited by 6
Ahmad, H., Ali, A., Ali, R., Khalil, A. T., Khan, I. N., Khan, M. M., & Alorini, M. (2024) · Neoplasia · doi:10.1016/j.neo.2024.100989 · Cited by 6
Computational Ensemble Gene Co-Expression Networks for the Analysis of Cancer Biomarkers
Figueroa-Martínez, J., Saz-Navarro, D. M., López, A. L., Rodríguez–Baena, D. S., & Gómez-Vela, F. (2024) · Informatics · doi:10.3390/informatics11020014 · Cited by 8
Rubion, E., Bourdon, M., Sebille, V., Blanchin, M., & Bertin, M. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08500-8 · Cited by 6
Al-Rudaini, A. T., Salih, L. A.-A., & Al-Dujaily, S. S. (2024) · Iraqi Journal of Science · doi:10.24996/ijs.2024.65.4.14 · Cited by 7
van Maaren, M. C., van Hoeve, J. C., Korevaar, J. C., van Hezewijk, M., Siemerink, E., Zeillemaker, A. M., Klaassen-Dekker, A., van Uden, D. J. P., Volders, J. H., Drossaert, C. H. C., et al. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08530-2 · Cited by 6
Self-citationFetene, D., Taylor, L. F., Ferrell, B., Deribe, B., Abdella, J., & Aynalem, A. (2024) · Palliative Care and Social Practice · doi:10.1177/26323524241253625 · Cited by 6
Carton, E., Mercier-Blas, A., Perret, C., & Bihan, M. L. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08579-z · Cited by 7
Pagan, E., Ruggeri, M., Bianco, N., Bucci, E. O., Graffeo, R., Borner, M., Giordano, M., Gianni, L., Rabaglio, M., Freschi, A., et al. (2024) · The Breast · doi:10.1016/j.breast.2024.103765 · Cited by 6
Kothari, R. K., Doshi, M. S., Chaithanya, P., Ct, S., Kumar, A., Mallavarapu, K. M., Nagarkar, R. V., Mahobia, V. K., Bhatt, N., Priyadarshini, K. L., et al. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.07.001 · Cited by 6
An insight into the therapeutic effects of isoliquiritigenin in breast cancer
Sharma, D., Dhobi, M., Lather, V., & Pandita, D. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03282-6 · Cited by 6
Qin, R., Yin, L., Wang, D., Cao, X., Shaibu, Z., Wang, X., Chen, P., Sui, D., Qiu, X., & Liu, D. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241265030 · Cited by 6
Recent advancements in small interfering RNA based therapeutic approach on breast cancer
Kalaimani, K., Balachandran, S., Boopathy, L. K., Roy, A., Jayachandran, B., Sankaranarayanan, S., & Arumugam, M. K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176877 · Cited by 13
Fakudze, N., Sarbadhikary, P., Abrahamse, H., & George, B. P. A. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.07.061 · Cited by 8
Gullick, G., Owen, C. N., Watkins, W. J., Cook, S., Helbrow, J., Reed, H., Squires, R., PARK, S. W., Weir, E., Aquilina, F., et al. (2024) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2024.100064 · Cited by 8
BRCA1/2 mutations and outcomes among Middle Eastern patients with early-onset breast cancer in Oman
Amri, W. S. A., Amri, A. H. A., Abri, A. A., Hughes, T. A., & Lawati, F. A. (2024) · The Oncologist · doi:10.1093/oncolo/oyae214 · Cited by 6
Feunaing, R. T., Tamfu, A. N., Yaya, A. J. G., Djoko, C. T., Ntchapda, F., Henoumont, C., Laurent, S., Talla, E., Anouar, E. H., Zingue, S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117370 · Cited by 6
National diagnostic reference levels for digital diagnostic and screening mammography in Uganda
Odongo, D., Musisi, A., Okello, R., Bongomin, F., & Erem, G. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294541 · Cited by 6
Peng, X., & Lu, Z. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s478573 · Cited by 7
Süer, İ., Abuaisha, A. M., Kaya, M., Abanoz, F., Çefle, K., Palanduz, Ş., & Öztürk, Ş. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0031 · Cited by 6
de Aviz, L. B. D. N., Alves, C. F., da Fonte, C. L., Corrêa, L. D. N. R., Progênio, R. C. S., Guedes, L. J. L., Neves, L. M. T., & Carneiro, S. R. (2024) · Integrative Cancer Therapies · doi:10.1177/15347354241256314 · Cited by 6
Chikkala, R., Bhayal, D., Rani, N., Modali, R., Bhatia, K. G., & Dubey, B. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00567-6 · Cited by 6
Novel Pt@BSA nanoparticles improve radiotherapeutic outcomes in breast cancer
Zhang, Y., Liu, Y., & Zheng, D. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md00792e · Cited by 3
Metadata
- Authors
- Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., & Soerjomataram, I.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- American Society of Clinical Oncology (US)
- Netherlands Comprehensive Cancer Organisation (NL)
- Corresponding author
- Morgan, Eileen
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 66
- Pages
- 15-23
- ISSN
- 0960-9776 (ISSN-L)
- PMC
- PMC9465273
- OpenAlex
- W4294189863
- Cited by
- 3,411
- References
- 43
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 997 · 2023: 516 · 2022: 23
- FWCI
- 284.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- Susan G. Komen (CCR19608129)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, global burden of disease, incidence, mortality, age-standardized rates, population projections, 2040 projections, regional variation, human development, cancer epidemiology
- MeSH terms
- Australia, Breast Neoplasms, Europe, Female, Forecasting, Humans, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review